Building on the successful achievements of Pfizer’s carbon emission reduction and green chemistry programs, we are working to contribute meaningfully to global efforts to reduce human impact on the environment.
Throughout the lifecycle of our products, our aspiration is to further reduce our carbon footprint and increase energy efficiency, decrease dependence on limited resources and reduce waste in order to help ensure a sustainable future for our patients, our global community and our company.
The International Trachoma Initiative is a partnership co-founded by Pfizer in 1998 with the goal of eliminating trachoma, the world’s leading cause of preventable blindness. As of this year, Pfizer, working as part of ITI, has distributed 500 million doses of an antibiotic used to treat the disease, and the Initiative has treated more than 100 million people suffering from trachoma.
Yesterday, Pfizer released its 2015 integrated annual review, an in-depth look into the company’s financial, social and environmental performance, as told through the voices of Pfizer colleagues. In short videos and testimonials, Pfizer scientists, researchers and business leaders share how they are working toward measurable change for people whose quality of life is affected by poor health or health risks.
Every year the National Health Service loses a staggering £950m because of missed appointments, or DNAs (did not attends) – no-shows who fail to cancel their appointments. Twelve million GP appointments are missed at a cost of £162m and 7.1m hospital appointments at a cost of £788m.
June 16th, 2015 /3BL Media/ - Americans suffer 1.5 million heart attacks and strokes each year, and cardiovascular disease is the leading cause of death in the United States. According to the U.S. Centers for Disease Control and Prevention (CDC), African-American men are 25 percent more likely to die from heart disease, compared to non-Hispanic white men. To help address this health disparity, the CDC Foundation is partnering with Pfizer and Quest Diagnostics to launch the Million Hearts® “Healthy is Strong” initiative.
150 cross-sector experts, innovators and policymakers will convene today at the National Press Club in Washington, D.C. to drive awareness of the opportunities for collaboration at the nexus of food and health
Washington, D.C. USA, May 13, 2015 /3BL Media/ --- The Future of Food: The Nexus of Food and Health summit—co-hosted by global affairs magazine Diplomatic Courier and Mars, Incorporated—will look at the vital role collaboration across sectors can play in sustainably addressing the world’s most pressing food and health challenges.
The Conference Board’s 21st Annual Leadership Development Conference
Washington, DC, April 27, 2015 /3BL Media/ - Amanda McArthur, VP , Global Pro Bono and Engagement at PYXERA Global will speak at The Conference Board’s 21st Annual Leadership Development Conference. Ms. McArthur will be a panelist on the panel, Global Leadership: Innovation in Executive Development at Pfizer, on April 30 in New York City.
Washington, D.C., November 10, 2014, /3BL Media/ – On November 13, 2014, Amanda MacArthur, Vice President of Global Pro Bono and Engagement at PYXERA Global will share her experience facilitating global business leadership development through global pro bono at the Boston University School of Management Executive Development Roundtable in Boston, Massachusetts.